VRAXVirax Biolabs Group Ltd
$0.2125
$0.0144
(7.27%)
Closed $0.2125
$0.0125
(5.88%)
After Hours
Mkt Cap$3.95M
Vol1.68M
Fundamentals
Mkt Cap
$3.95M
Volume
-
52W High
$1.14
52W Low
$0.10
PE Ratio
-0.17
Avg. Volume
53.89M
EPS (Annual)
-$1.62
Rev/Employee
$333.21
Earnings
-
38
Bearish Sentiment
How do you feel about VRAX?
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes PR Newswire LONDON, May 26, 2026 LONDON, May 26...
PR Newswire
Why Is Virax Biolabs (VRAX) Stock Trending Overnight?
Virax Biolabs Group Limited shares rose 17.36% after hours following heavy intraday gains and disclosure of a new 4.99% hedge fund stake.read more...
Benzinga
Nasdaq Down 200 Points; Brady Earnings Top Views
US stocks lower as Nasdaq falls 200 points, Dow down 0.04% and S&P 500 down 0.37%. Energy shares up 1.8%, tech stocks down 1.6%. Brady Corp reports strong earnings. Sunshine Biopharma, Virax Biolabs...
Benzinga
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones...
PR Newswire
Breakthrough Science, AI Deals, and Nasdaq Warnings Collide in a High-Stakes Market Surge
A volatile mix of scientific breakthroughs, aggressive expansion, fresh capital inflows, and compliance risks is defining the current small- and micro-cap landscape. $KBLB, $RMSG, $VRAX, $ALMU, $IMA, $RCT, $NTRA, $ALLO, $RECT, $FFAI
24-7 Market News
AI and Biotech Enter a Stock Picker’s Market
The market is sending a mixed but telling signal: innovation is accelerating, but only the most disciplined and well-positioned companies are keeping pace. Across AI, biotech, and micro-cap tech, recent developments highlight a widening divide between firms gaining validation and those fighting to maintain footing in public markets. $BFRG, $TGNT, $LTRN, $VRAX, $KIDZ, $HKIT
24-7 Market News
What's Behind The Jump In Virax Biolabs Stock?
Shares of Virax Biolabs Group are soaring Tuesday after it secured several regulatory certifications paving the way for clinical validation.read more...
Benzinga
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD...
PR Newswire
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why
Virax Biolabs Group Limited (VRAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Penny Stocks To Keep An Eye On - December 3rd
iRobot, Richtech Robotics, Bitfarms, Virax Biolabs Group, Nauticus Robotics, Incannex Healthcare, and Fusion Fuel Green are the seven Penny stocks to watch today, according to MarketBeat's stock...
MarketBeat
<
1
2
...
>